Sudeep Pharma Ltd Logo

Sudeep Pharma Ltd IPO

BSELot: 25

LISTEDMAINBOARD
Issue Price593
Listing730
Current618
Price Band
563 - ₹593
Lot Size
25
Issue Size
₹895 Cr
GMP
0
Subscription
1.43x

IPO Schedule

1
Open
21 Nov
2
Close
25 Nov
3
Allotment
26 Nov
4
Listing
28 Nov

About Sudeep Pharma Ltd

Sudeep Pharma Ltd is a pharmaceutical company focused on manufacturing and marketing active pharmaceutical ingredients (APIs) and finished dosage formulations. They cater to both domestic and international markets, primarily focusing on niche therapeutic segments.

Subscription Status

QIB
0.09x
NII
3.01x
Retail
1.53x
CategoryDay 3Day 2Day 1
QIB213.08x0.13x0.09x
NII116.72x12.03x3.01x
Retail15.65x5.02x1.53x
Total93.71x5.13x1.43x

Risk Factors

Reliance on specific APIs and vulnerability to price fluctuations in raw materials.
Exposure to regulatory risks and compliance requirements in the pharmaceutical industry.
Competition from established players and new entrants in the API and formulation markets.

Promoters & Management

The key management team includes Sujit Jaysukh Bhayani, the Managing Director and Chairman, who has 34 years of experience in the pharmaceuticals industry. Shanil Sujit Bhayani is the Whole-time Director, responsible for planning sales and marketing strategies and product development. Ajay Shrirang Kandelkar is a Whole-time Director, responsible for strategy planning and financial management. Reshma Suresh Patel, Samaresh Parida and Sujit Gulati are Independent Directors. Dimple Ashwinbhai Mehta is the Company Secretary and Compliance Officer. Ketan Jagdishchandra Vyas is the Chief Financial Officer.